Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) generates a steady flow of corporate, financial, and strategic news as it transitions into Accendra Health, Inc. and refocuses on home-based care. Company press releases and SEC filings describe a multi-step transformation that includes the sale of its Products & Healthcare Services (P&HS) segment, a shift toward a pure play home-based care platform centered on the Patient Direct business, and a corporate name and ticker change to Accendra Health, Inc. and ACH on the New York Stock Exchange.
News related to OMI has recently covered transaction announcements, such as the definitive agreement and subsequent completion of the sale of the P&HS segment to an affiliate of Platinum Equity, along with details of the retained equity stake and associated tax attributes. Earnings releases provide quarterly and year-to-date financial results for continuing operations, which primarily represent the Patient Direct segment and certain functional operations, and discuss management’s views on the company’s financial outlook and strategic priorities.
Investors and observers will also find corporate governance and leadership updates in the news flow, including executive appointments, role changes, and amendments to executive compensation and retirement plans that are connected to the company’s evolving structure. Additional items include announcements of participation in investor conferences, where management presents the company’s strategy and financial profile, and commercial agreements such as the national preferred DME network arrangement involving Apria and Byram with Optum Health.
This news page for OMI serves as a historical archive of Owens & Minor’s communications as it moves toward operating as Accendra Health, Inc. under the ACH ticker. Readers can use it to trace the company’s shift from a combination of hospital-focused distribution and home-based care toward a focused Patient Direct platform, as well as to follow key regulatory filings, transaction milestones, and strategic announcements.
Owens & Minor (NYSE: OMI) has announced its acquisition of Apria (NASDAQ: APR) at $37.50 per share, totaling approximately $1.45 billion in equity and $1.6 billion including assumed debt. This strategic move aims to enhance healthcare services from hospital to home, diversify revenue streams, and strengthen its Patient Direct offering. The deal, providing a premium of 26-30% over Apria’s recent share prices, is expected to close in H1 2022, pending regulatory approvals. Both companies anticipate significant synergies, positioning Owens & Minor for future growth in the $50 billion home healthcare market.
Owens & Minor, Inc. (NYSE: OMI) reports on the progress of the Owens & Minor Foundation since its launch in June 2021, emphasizing its commitment to healthcare, environment, and diversity and inclusion. The organization has supported various charitable groups, including the Boys & Girls Clubs of Metro Atlanta and St. Jude Children's Research Hospital. Shana C. Neal, EVP and Chief Human Resources Officer, highlights the importance of community engagement in achieving the foundation's goals. The foundation will focus on social determinants of health in 2022.
Owens & Minor, Inc. recognized leaders in diversity and inclusion at the 2021 Earl G. Reubel Awards, held virtually on December 16. The awards, established in partnership with Kerma Medical Products and the Healthcare Supplier Diversity Alliance, honored individuals and organizations across three categories: Civic Leadership, Diverse Enterprise, and Large Corporation. Deborah Williams, SDVOSB Laboratory, and Premier, Inc. were among the key awardees. Edward A. Pesicka, CEO, emphasized that these winners reflect a commitment to supplier diversity, critical for advancing healthcare.
Owens & Minor, Inc. (NYSE: OMI) has announced that Andy Long, Executive Vice President & Chief Financial Officer, will present at the Bank of America Securities Leveraged Finance Conference on November 30, 2021, at 3:45 PM EST. A live webcast and replay of the presentation will be accessible via the Investor Relations section of the Owens & Minor website. The company is a leading global healthcare solutions provider, serving over 4,000 customers with a workforce of more than 15,000 individuals, primarily based in the Americas.
Owens & Minor has launched its new consumer brand, SAFESKIN*, featuring task-focused Nitrile Gloves sold in POP-N-GO* packs. These packs are designed for convenience, allowing users to prepare for various tasks while ensuring protection from germs and chemicals. The gloves come in different levels of protection and are color-coded for easy selection. The launch responds to increased consumer demand for reliable protective gear, with data indicating a significant uptick in glove usage across various sectors.
Owens & Minor announced that board members Aster Angagaw and retired Lt. Gen. Gwendolyn Bingham were included in Savoy Magazine's list of 2021 Most Influential Black Corporate Directors. This recognition underscores the company's commitment to diversity and highlights the extensive leadership experience these directors bring. Bingham's military background and Angagaw’s experience in growth and transformation are seen as vital assets for Owens & Minor's mission to advance healthcare.
Owens & Minor (NYSE-OMI) reported a strong Q3 2021, showing over 14% year-over-year revenue growth at $2.502 billion. Adjusted net income reached $56 million, with EPS of $0.74. The company achieved operating income of $79.3 million, despite inflation pressures. They narrowed 2021 guidance, expecting adjusted EPS between $3.90 and $4.10 and adjusted EBITDA of $475 million to $500 million. Ongoing growth in Global Solutions and Global Products segments has contributed to a strengthened financial position.
Owens & Minor, Inc. (NYSE: OMI) has announced a dividend payment of $0.0025 per share for the fourth quarter of 2021. This payment will be made on December 31, 2021, to shareholders of record as of December 15, 2021. The company, based in Richmond, Virginia, provides healthcare solutions and has been operational since 1882, serving over 4,000 customers globally with a workforce of more than 15,000.
Owens & Minor, Inc. (NYSE: OMI) is set to release its third quarter 2021 financial results on November 3, 2021, before the market opens. A conference call to discuss these results will be held at 8:30 a.m. EDT on the same day. Interested participants can dial in at 866-393-1604 or 1-224-357-2191 internationally. The call will also be accessible via a webcast on the company's website. Owens & Minor is a global healthcare solutions provider, serving over 4,000 healthcare customers with a focus on product manufacturing and distribution.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
